Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 1
1991 2
1992 2
1993 2
1995 6
1996 1
1997 2
1998 3
1999 3
2000 3
2001 6
2002 2
2003 2
2004 5
2005 5
2006 9
2007 14
2008 28
2009 29
2010 13
2011 11
2012 8
2013 13
2014 20
2015 13
2016 17
2017 13
2018 9
2019 20
2020 27
2021 24
2022 19
2023 18
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ; PREVENT Study Group. Wingerchuk DM, et al. Ann Neurol. 2021 Jun;89(6):1088-1098. doi: 10.1002/ana.26049. Epub 2021 Feb 27. Ann Neurol. 2021. PMID: 33586143 Free PMC article. Clinical Trial.
Dietary fatty acid composition drives neuroinflammation and impaired behavior in obesity.
Sanchez C, Colson C, Gautier N, Noser P, Salvi J, Villet M, Fleuriot L, Peltier C, Schlich P, Brau F, Sharif A, Altintas A, Amri EZ, Nahon JL, Blondeau N, Benani A, Barrès R, Rovère C. Sanchez C, et al. Among authors: altintas a. Brain Behav Immun. 2024 Mar;117:330-346. doi: 10.1016/j.bbi.2024.01.216. Epub 2024 Feb 2. Brain Behav Immun. 2024. PMID: 38309640 Free article.
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study.
Spelman T, Simoneau G, Hyde R, Kuhelj R, Alroughani R, Ozakbas S, Karabudak R, Yamout BI, Khoury SJ, Terzi M, Boz C, Horakova D, Kubala Havrdova E, Weinstock-Guttman B, Patti F, Altintas A, Mrabet S, Gouider R, Inshasi J, Shaygannejad V, Eichau S, Ward WL, Butzkueven H; MSBase Investigators. Spelman T, et al. Among authors: altintas a. Neurology. 2024 Apr 9;102(7):e208114. doi: 10.1212/WNL.0000000000208114. Epub 2024 Mar 6. Neurology. 2024. PMID: 38447093 Free PMC article.
Treatment of MOG antibody associated disorders: results of an international survey.
Whittam DH, Karthikeayan V, Gibbons E, Kneen R, Chandratre S, Ciccarelli O, Hacohen Y, de Seze J, Deiva K, Hintzen RQ, Wildemann B, Jarius S, Kleiter I, Rostasy K, Huppke P, Hemmer B, Paul F, Aktas O, Pröbstel AK, Arrambide G, Tintore M, Amato MP, Nosadini M, Mancardi MM, Capobianco M, Illes Z, Siva A, Altintas A, Akman-Demir G, Pandit L, Apiwattankul M, Hor JY, Viswanathan S, Qiu W, Kim HJ, Nakashima I, Fujihara K, Ramanathan S, Dale RC, Boggild M, Broadley S, Lana-Peixoto MA, Sato DK, Tenembaum S, Cabre P, Wingerchuk DM, Weinshenker BG, Greenberg B, Matiello M, Klawiter EC, Bennett JL, Wallach AI, Kister I, Banwell BL, Traboulsee A, Pohl D, Palace J, Leite MI, Levy M, Marignier R, Solomon T, Lim M, Huda S, Jacob A. Whittam DH, et al. Among authors: altintas a. J Neurol. 2020 Dec;267(12):3565-3577. doi: 10.1007/s00415-020-10026-y. Epub 2020 Jul 4. J Neurol. 2020. PMID: 32623595 Free PMC article.
Auricular Lobuloplasty.
Altıntaş A, Çelik M, Yeğin Y, Kayabaşoğlu G. Altıntaş A, et al. Turk Arch Otorhinolaryngol. 2017 Dec;55(4):172-176. doi: 10.5152/tao.2017.2675. Epub 2017 Dec 1. Turk Arch Otorhinolaryngol. 2017. PMID: 29515930 Free PMC article.
Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Arnett S, Chew SH, Leitner U, Hor JY, Paul F, Yeaman MR, Levy M, Weinshenker BG, Banwell BL, Fujihara K, Abboud H, Dujmovic Basuroski I, Arrambide G, Neubrand VE, Quan C, Melamed E, Palace J, Sun J, Asgari N, Broadley SA; Guthy Jackson International Clinical Consortium*. Arnett S, et al. J Neurol. 2024 Aug;271(8):4794-4812. doi: 10.1007/s00415-024-12452-8. Epub 2024 Jul 3. J Neurol. 2024. PMID: 38958756 Free PMC article. Review.
Author's reply.
Beyazyildiz E, Beyazyildiz Ö, Arifoglu HB, Altintas AK, Köklü SG. Beyazyildiz E, et al. Among authors: altintas ak. Indian J Ophthalmol. 2015 Jan;63(1):78. Indian J Ophthalmol. 2015. PMID: 25834852 Free PMC article. No abstract available.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Spelman T, Ozakbas S, Alroughani R, Terzi M, Hodgkinson S, Laureys G, Kalincik T, Van Der Walt A, Yamout B, Lechner-Scott J, Soysal A, Kuhle J, Sanchez-Menoyo JL, Blanco Morgado Y, Spitaleri D, van Pesch V, Horakova D, Ampapa R, Patti F, Macdonell R, Al-Asmi A, Gerlach O, Oh J, Altintas A, Tundia N, Wong SL, Butzkueven H. Spelman T, et al. Among authors: altintas a. Mult Scler. 2023 Feb;29(2):221-235. doi: 10.1177/13524585221137502. Epub 2022 Nov 26. Mult Scler. 2023. PMID: 36433775 Free PMC article.
A 52-Year-Old Man With Progressive Weakness and Incontinence.
Altintas A, Danyeli AE, Bozkurt SB, Uysal SP, Akpek S, Aygun MS, Akay OM, Kahyaoglu B, Peker S, Ure UB, Ferhanoglu B. Altintas A, et al. Neurohospitalist. 2022 Apr;12(2):307-311. doi: 10.1177/19418744211039586. Epub 2021 Aug 13. Neurohospitalist. 2022. PMID: 35419156 Free PMC article.
314 results